Clinical Trials Logo

Epilepsy, Rolandic clinical trials

View clinical trials related to Epilepsy, Rolandic.

Filter by:

NCT ID: NCT01521130 Completed - Clinical trials for Benign Childhood Epilepsy With Centro-Temporal Spikes

Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children

FIRST
Start date: January 2012
Phase: Phase 1
Study type: Interventional

This project examines how seizures, and abnormal brain activity, affect language skill in children with Benign Childhood Epilepsy with Centro-Temporal Spikes (BECTS). BECTS is a common type of childhood epilepsy, and while BECTS patients stop having seizures by their late teenage years, many studies have shown that these children have language problems that may lead to academic and social difficulties. Using standardized language testing, monitoring of brain activity, and MRI brain imaging, this project aims to determine what particular combination of BECTS symptoms put children most at risk for language problems and whether treatment with anti-epileptic medications may be helpful.

NCT ID: NCT01515436 Completed - Epilepsy Clinical Trials

The Effect of Music Periodicity on Interictal Epileptiform Discharges

Start date: February 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if having children listen to the music of Wolfgang Amadeus Mozart (Sonata for Two Pianos in D Major, K. 448) will lessen the amount of spike discharges on his/her Electroencephalography (EEG). These spike discharges often occur during a 24 hour period in the EEG of a child with Benign Childhood Epilepsy with Centrotemporal Spikes (BCECTS), or Rolandic Epilepsy. Should there be a decrease in the amount of spike discharges after listening to Mozart's music, this information may lead to new understanding and possible treatments for epilepsy.

NCT ID: NCT01335425 Completed - Rolandic Epilepsy Clinical Trials

The Rolandic Epilepsy/ESES/Landau-Kleffner Syndrome and Correlation With Language Impairment Study

REL
Start date: October 2010
Phase: N/A
Study type: Observational

In clinical practice language impairment is frequently reported in association with nocturnal epileptiform activity. There is a spectrum of epileptic conditions that are characterized by nocturnal epileptiform activity. From mild to severe this spectrum involves: Rolandic epilepsy (RE), nocturnal frontal lobe epilepsy (NFLE), Landau-Kleffner syndrome (LKS) and electrical status epilepticus during slow wave sleep (ESES). The exact characteristic of the relationship between nocturnal epileptiform activity and language impairment is yet to be explored. The investigators suggest that nocturnal epileptiform EEG discharges and nocturnal epileptic seizures during development will cause diseased neuronal networks that involve language. The diseased neuronal networks are less efficient compared with normal neuronal networks. Objective: Identification of a diseased neuronal network characteristic in children with nocturnal epileptiform activity, which can explain language impairment in these children. For this the investigators will use functional magnetic resonance imaging (MRI) to analyse brain activity and diffusion weighted MRI to investigate white matter connectivity.

NCT ID: NCT01046760 Active, not recruiting - Rolandic Epilepsy Clinical Trials

Scholar Performance and Praxis Assessment in Children With Rolandic Epilepsy

Start date: September 2009
Phase: N/A
Study type: Observational

Rolandic Epilepsy is the most common form of childhood epilepsy. It is classified as idiopathic, age-related epilepsy syndrome with benign evolution. The absence of neuropsychological impairment is part of the criteria of benignity of this epilepsy syndrome. However recently have been suggested several deficits related to attention and language. The purpose of this study was assess school performance and to investigate problems of praxis in patients with rolandic epilepsy as compared to a control group composed of normal children with age, gender and educational level equivalents.

NCT ID: NCT00471744 Terminated - Epilepsy, Rolandic Clinical Trials

HEAD-Study Optimizing the Treatment of Children With BECTS

HEAD
Start date: June 2006
Phase: Phase 3
Study type: Interventional

The investigators hypothesize that Levetiracetam is as effective as Sulthiame in the treatment of children with BECTS. Patients entering the HEAD-Studie are either treated with Leveitracetam or Sulthiame over a 6 months period. Patients are equally randomised to one of the two treatment regimens. Administration of medication as blinded capsules.

NCT ID: NCT00282854 Completed - Epilepsy Clinical Trials

Genetics of Rolandic Epilepsy

Start date: January 2005
Phase:
Study type: Observational

The purpose of this study is to find the genes that cause Rolandic epilepsy and its related traits.

NCT ID: NCT00216567 Completed - Epilepsy, Rolandic Clinical Trials

Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy

Start date: December 2002
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of Topiramate in comparison to Carbamazepine in Benign rolandic epilepsy.